STOCK TITAN

Immuron (IMRN) files Form 6-K on ASX securities quotation and cleansing notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Immuron Limited furnished a Form 6-K to provide U.S. investors with copies of two announcements it filed with the Australian Securities Exchange. The announcements, dated December 16, 2025, are an Application for quotation of securities and a related Cleansing Notice, both attached as exhibits to the report.

Positive

  • None.

Negative

  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of December 2025

 

Commission File Number: 001-38104

 

IMMURON LIMITED

(Name of Registrant)

 

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ☐      No ☒

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

 

 

 

 

 

IMMURON LIMITED

 

EXPLANATORY NOTE

 

Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on December 16, 2025 titled:

 

99.1   Application for quotation of securities
99.2   Cleansing Notice

 

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

 

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

1

 

 

EXHIBITS

 

Exhibit
Number
  Description
99.1   Application for quotation of securities
99.2   Cleansing Notice

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  IMMURON LIMITED
     
Date: December 16, 2025 By: /s/ Phillip Hains
    Phillip Hains
    Company Secretary

 

3

 

 

FAQ

What does Immuron Limited (IMRN) disclose in this December 2025 Form 6-K?

Immuron Limited’s Form 6-K forwards two Australian Securities Exchange announcements to U.S. investors. These are an Application for quotation of securities and a Cleansing Notice dated December 16, 2025, both attached as exhibits to the report for informational purposes.

What exhibits are attached to Immuron Limited’s (IMRN) December 2025 Form 6-K?

The Form 6-K includes two exhibits. Exhibit 99.1 is an Application for quotation of securities, and Exhibit 99.2 is a Cleansing Notice. Both originate from announcements Immuron Limited lodged with the Australian Securities Exchange on December 16, 2025.

Is Immuron Limited’s (IMRN) December 2025 Form 6-K considered filed under the Exchange Act?

The report states it shall not be deemed “filed” for purposes of the Exchange Act. It is furnished instead, and it will only be incorporated into future Securities Act filings if those documents specifically reference this Form 6-K and its exhibits.

Why did Immuron Limited (IMRN) issue a Cleansing Notice referenced in the Form 6-K?

The Form 6-K indicates that Immuron Limited published a Cleansing Notice to the Australian Securities Exchange. While details are in the attached exhibit, such notices typically accompany new securities quotations to provide required disclosure to the market and investors.

Who signed Immuron Limited’s (IMRN) December 2025 Form 6-K?

The Form 6-K was signed on behalf of Immuron Limited by Company Secretary Phillip Hains. The signature block shows his name, title, and the signature date of December 16, 2025, confirming the company’s authorization of the furnished information and attached exhibits.

What is the relationship between Immuron’s ASX announcements and this Form 6-K?

The company first published the Application for quotation of securities and Cleansing Notice on the Australian Securities Exchange. Immuron then furnished these same announcements to U.S. markets by attaching them as exhibits 99.1 and 99.2 to this Form 6-K report.
Immuron Ltd

NASDAQ:IMRN

View IMRN Stock Overview

IMRN Rankings

IMRN Latest News

IMRN Latest SEC Filings

IMRN Stock Data

6.46M
8.17M
Biotechnology
Healthcare
Link
Australia
Carlton